- Home
- HUIZ vs GDTC Comparison
HUIZ vs GDTC Comparison
Compare HUIZ & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- GDTC
- Stock Information
- Founded
- HUIZ 2006
- GDTC 2018
- Country
- HUIZ China
- GDTC Singapore
- Employees
- HUIZ N/A
- GDTC N/A
- Industry
- HUIZ Specialty Insurers
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- GDTC Health Care
- Exchange
- HUIZ Nasdaq
- GDTC Nasdaq
- Market Cap
- HUIZ 25.3M
- GDTC 21.5M
- IPO Year
- HUIZ 2020
- GDTC 2023
- Fundamental
- Price
- HUIZ $3.06
- GDTC $1.88
- Analyst Decision
- HUIZ Hold
- GDTC Buy
- Analyst Count
- HUIZ 1
- GDTC 1
- Target Price
- HUIZ $2.30
- GDTC $5.00
- AVG Volume (30 Days)
- HUIZ 721.2K
- GDTC 14.8K
- Earning Date
- HUIZ 09-12-2025
- GDTC 01-01-0001
- Dividend Yield
- HUIZ N/A
- GDTC N/A
- EPS Growth
- HUIZ N/A
- GDTC N/A
- EPS
- HUIZ 0.25
- GDTC N/A
- Revenue
- HUIZ $186,519,166.00
- GDTC $368,838.00
- Revenue This Year
- HUIZ $11.94
- GDTC $5.37
- Revenue Next Year
- HUIZ $8.15
- GDTC N/A
- P/E Ratio
- HUIZ $15.34
- GDTC N/A
- Revenue Growth
- HUIZ 19.12
- GDTC N/A
- 52 Week Low
- HUIZ $1.50
- GDTC $1.20
- 52 Week High
- HUIZ $10.58
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- HUIZ 53.66
- GDTC 46.04
- Support Level
- HUIZ $2.70
- GDTC $1.82
- Resistance Level
- HUIZ $4.53
- GDTC $2.28
- Average True Range (ATR)
- HUIZ 0.30
- GDTC 0.12
- MACD
- HUIZ 0.09
- GDTC 0.00
- Stochastic Oscillator
- HUIZ 28.99
- GDTC 13.04
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.